Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks
Cell Biology International · 2025-12 · 49 (12) · 1705-1715
DOI: 10.1002/cbin.70086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 30.09.2025. Verfasst von Yeliz Demir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Türkiye. Hauptthemen laut MEDLINE: Umbelliferones, Doxorubicin, Apoptosis, Cardiotoxicity. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: This study was supported by the Unit of Scientific Research Projects of University of Ardahan (2021-003)..
Abstract (Originalsprache)
Doxorubicin (DOX), although widely used as a potent chemotherapeutic agent, is limited by its dose‐dependent cardiotoxicity. Esculetin (E), a naturally occurring coumarin derivative, has been reported to exert antioxidant and anti‐apoptotic effects in various tissues. This study aimed to evaluate the cardioprotective effects of esculetin against DOX‐induced cardiac injury in rats by examining changes in the expression of genes related to apoptosis, oxidative stress, and mitochondrial function. Male Wistar rats were randomly assigned into six groups (Control, DOX, E50, E100, DOX + E50, DOX + E100). Cardiotoxicity was induced by administering DOX was administered as six intraperitoneal injections of 5 mg/kg each over 14 days (cumulative dose = 30 mg/kg). Serum cardiac markers (CK‐MB, LDH, and cTn‐I) were measured, and cardiac tissues were subjected to histopathological examination and RT‐qPCR analysis for target gene expression. In addition, hierarchical clustering heatmap was employed to evaluate multidimensional gene expression patterns across groups. DOX treatment significantly elevated serum cardiac injury markers and upregulated pro‐apoptotic genes ( Casp3, Casp9, Anf, Bnp, β‐Mhc ), while downregulating genes associated with mitochondrial biogenesis ( Pgc1α ) and antioxidant response ( Foxo1, Cox2 ). These findings suggest esculetin as a potential adjunctive candidate for cardioprotection during DOX chemotherapy. However, given the absence of protein‐level validation, further studies are warranted to confirm whether the observed gene expression changes translate into corresponding alterations at the protein level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Türkiye.
- Department of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Türkiye.
- East Anatolian High Technology Research and Application Center (DAYTAM), Atatürk University, Erzurum, Türkiye.
- Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Türkiye.
- Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
ORCID-Profile: Yeliz Demir
Förderung
- This study was supported by the Unit of Scientific Research Projects of University of Ardahan (2021-003).
Zitieren
APA
Demir, Y., Ceylan, H., Karağaç, M. S., Türkeş, C., Karaman, M., & Beydemir, Ş. (2025). Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks. Cell Biology International, 49(12), 1705-1715. https://doi.org/10.1002/cbin.70086
Vancouver
Demir Y, Ceylan H, Karağaç MS, Türkeş C, Karaman M, Beydemir Ş. Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks. Cell Biology International. 2025;49(12):1705-1715. doi:10.1002/cbin.70086
BibTeX
@article{Demir2025,
author = {Demir, Yeliz and Ceylan, Hamid and Karağaç, Medine Sibel and Türkeş, Cüneyt and Karaman, Melike and Beydemir, Şükrü},
title = {Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks},
journal = {Cell Biology International},
year = {2025},
volume = {49},
number = {12},
pages = {1705--1715},
doi = {10.1002/cbin.70086}
}
EUVIMED